Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health condition. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results may vary.
Yes, an injection site reaction is a known side effect of Zepbound and the other GLP-1 shots. In the Zepbound weight-loss trials, 6–8% of people reported one, compared with 2% on placebo, and the label groups bruising, redness, itching, pain and rash at the site under that one heading.
Most reactions stay at the spot where you injected. A reaction that spreads, or comes with swelling of the face or throat or trouble breathing, is a different thing: the labels call that a serious allergic reaction, and it needs emergency care. The signs are listed below.
How common are injection site reactions? The label numbers
From the current US prescribing information for each drug:
| Injection site reactions (drug vs placebo) | Where in the label | What the label counts | |
|---|---|---|---|
| Zepbound (tirzepatide) | 6% at 5 mg, 8% at 10 mg, 8% at 15 mg vs 2% placebo | Table 1, section 6.1 (weight-reduction Studies 1 and 2) | Injection site bruising, erythema (redness), pruritus (itching), pain, rash, and "injection site reaction" |
| Mounjaro (tirzepatide) | 3.2% vs 0.4% placebo | Section 6.1 text; not in Table 1, which lists reactions at 5% or more | Not broken down |
| Wegovy (semaglutide) | 1.4% vs 1% placebo | Section 6.1 text (adult weight-reduction trials); not in Table 3 | Pruritus, erythema, inflammation, induration (hardening) and irritation |
| Ozempic (semaglutide) | 0.2% (the label gives no placebo figure) | Section 6.1 text | Injection-site discomfort, erythema |
| Saxenda (liraglutide, daily) | 13.9% vs 10.5% placebo | Table 2, section 6.1 | Mostly erythema, pruritus and rash at the site |
The trials differ, so the labels warn that rates cannot be compared directly between drugs. For "Zepbound rash," the Zepbound label also lists hypersensitivity reactions at 5% at every dose vs 3% on placebo, and says most of them were skin reactions such as rash and itching. Severe hypersensitivity reactions occurred in 0.1% of people on Zepbound and in no one on placebo.
For the full side-effect picture by drug, see Zepbound side effects, Mounjaro side effects, Wegovy side effects and Ozempic side effects.
Why does my Zepbound injection site itch or turn red?
The labels do not explain the cause of a local reaction. They do report one clear link: antibodies to the drug. In the Zepbound trials, injection site reactions occurred in 11.3% of people who developed anti-tirzepatide antibodies, compared with 1% of people who did not. The Mounjaro label reports the same pattern (4.6% vs 0.7%).
Technique is the part you control. The instructions for use (IFU) tell you to rotate sites and to avoid skin that is already tender, bruised or hard. The steps are below.
What does a reaction look like, and how long does it last?
The labels describe the reactions in these words: redness, itching, pain, bruising, rash, inflammation and induration (a firm or hard area) at the spot of the shot. They do not give a typical time course. A log of each shot and each reaction shows your own pattern.
A lump is worth a separate note. The Zepbound vial instructions say to rotate sites within an area "to reduce your risk of getting lipodystrophy (pits in skin or thickened skin) and localized cutaneous amyloidosis (skin with lumps)," and not to inject where the skin has pits, is thickened, or has lumps. The Saxenda label says to rotate sites to reduce the risk of cutaneous amyloidosis, and lists cutaneous amyloidosis in its postmarketing reports. A lump that stays is a reason to show your prescriber the spot.
What helps: a site-care routine from the instructions for use
- Rotate every week. All four weekly labels say to rotate injection sites with each dose. You can use the same body area, but pick a different spot in it. Use the sites your label allows: Zepbound and Mounjaro list the abdomen and thigh, and the back of the upper arm only if another person gives the shot. Wegovy and Ozempic list the abdomen, thigh and upper arm. The Wegovy instructions add: keep at least 2 inches from your belly button.
- Skip irritated skin. The Wegovy instructions say not to inject where the skin is tender, bruised, red or hard, and to avoid scars and stretch marks. The Zepbound vial instructions say the same for tender, bruised, scaly or hard skin, scars and damaged skin.
- Let the skin dry after cleaning. The Wegovy and Ozempic instructions say to clean the site with an alcohol swab (or soap and water, in the Wegovy pen instructions) and let the skin dry before you inject. The Zepbound single-dose pen instructions do not include a skin-cleaning step, so follow the IFU for your own pen or vial.
- Don't heat your pen. The Zepbound and Mounjaro pen instructions say it is not necessary to warm the pen to room temperature. The Wegovy and Ozempic prefilled-syringe instructions say never to warm the syringe with hot water or a microwave.
- If it bleeds, press lightly. The Wegovy and Ozempic instructions say to press the site lightly with a gauze pad or cotton ball if blood appears.
- Keep other injections off that spot. The Zepbound vial instructions say not to inject Zepbound in the same site used for other medicines.
- Ask before you treat it. Ask your prescriber or pharmacist before you use an antihistamine, a hydrocortisone cream or anything similar, including before a shot.
The free injection site tracker on our website keeps a simple rotation map, so you don't have to remember last week's spot.
When is an injection site reaction an emergency?
Stop using the medicine and get medical help right away if you have any sign of a serious allergic reaction. The Zepbound, Mounjaro, Wegovy and Ozempic medication guides all list the same signs:
- Swelling of your face, lips, tongue or throat
- Problems breathing or swallowing
- Severe rash or itching
- Fainting or feeling dizzy
- Very rapid heartbeat
The labels report anaphylaxis and angioedema with these drugs. If you had one of these reactions to any GLP-1 medicine before, tell your prescriber. All four labels say it is unknown whether people with that history are more likely to react to the drug.
Call your prescriber if a reaction spreads beyond the injection spot, gets bigger or more painful with each shot instead of fading, or leaves a lump that does not go away. Don't skip or delay a dose on your own because of a skin reaction. That decision belongs to your prescriber.
What to track (and why it helps)
GLP AI's dose log records the injection site with each shot. In the side-effect log, pick injection site reaction, rash, itchiness, swelling or bruising from the catalog, and give each entry a severity from 1 to 10. Over a few weeks the Zepbound side effect tracker shows whether reactions follow one site, one dose step or one day of the week. The estimated medication level chart puts each entry on your dose week. The Zepbound half-life calculator draws the same curve.
Before an appointment, export the doctor report PDF and share it yourself. It covers your medication history, the estimated medication curve, weight and side effects over time. See doctor visit prep for what to bring, and the GLP-1 side effects hub for other symptoms, such as nausea and hair loss.
Zepbound Injection Site Reaction FAQ
Is an injection site reaction on Zepbound normal?
It is a known side effect. In the Zepbound weight-loss trials, 6% to 8% of people reported an injection site reaction (bruising, redness, itching, pain or rash at the site) compared with 2% on placebo. A reaction that spreads, or swelling of the face or throat, trouble breathing, fainting or a very rapid heartbeat, is not a local reaction and needs emergency care.
Why is my Zepbound injection site itchy and red?
The label groups itching and redness under injection site reactions. Rotating sites each week and avoiding tender, bruised or hard skin follows the instructions for use. Ask your prescriber or pharmacist before using an antihistamine or a cream.
Is a Zepbound rash an allergic reaction?
It can be. The Zepbound label lists hypersensitivity reactions in 5% of people vs 3% on placebo, and most were skin reactions such as rash and itching. A rash at the injection site only is counted as an injection site reaction. A rash that spreads should go to your prescriber. A severe rash with swelling of the face or throat or trouble breathing needs emergency care.
Why do I get a lump or bruise after my injection?
The Zepbound label counts bruising as an injection site reaction. The Zepbound vial instructions say rotating sites within an area reduces the risk of lipodystrophy (pits or thickened skin) and localized cutaneous amyloidosis (skin with lumps), and say not to inject into lumps, bruises or hard skin. Show your prescriber a lump that does not go away.
Do Ozempic and Wegovy cause injection site reactions too?
Yes, but the labels report lower rates than for tirzepatide: 1.4% on Wegovy vs 1% on placebo, and 0.2% on Ozempic, with no placebo figure given. Different trials mean the rates cannot be compared directly.
Sources verified 2026-10-26
- Zepbound prescribing information (USPI, revised 08/2026): Table 1 injection site reactions (placebo 2%; 5 mg 6%; 10 mg 8%; 15 mg 8%) and footnote d; hypersensitivity reactions (Table 1; section 6.1); severe hypersensitivity 0.1% (section 5.6); antibody association (section 6.1); sections 2 and 4.
- Zepbound full label with Medication Guide and Instructions for Use (DailyMed): serious allergic reaction signs; single-dose pen and vial instructions on rotation, skin to avoid, lipodystrophy and cutaneous amyloidosis, and pen temperature.
- Mounjaro prescribing information (USPI, revised 08/2026): injection site reactions 3.2% vs 0.4% placebo and antibody data (section 6.1); hypersensitivity (section 5.4).
- Mounjaro Medication Guide and Mounjaro pen Instructions for Use: serious allergic reaction signs; pen temperature.
- Wegovy prescribing information, Medication Guide and Instructions for Use (revised 06/2026): injection site reactions 1.4% vs 1% placebo (section 6.1); section 2.1 rotation; hypersensitivity (section 5.7); Medication Guide; pen and prefilled-syringe instructions.
- Ozempic prescribing information, Medication Guide and Instructions for Use: injection site reactions 0.2% (section 6.1); section 2.1 rotation; hypersensitivity (section 5.8); Medication Guide; pen and prefilled-syringe instructions.
- Saxenda prescribing information: Table 2 injection site reaction 13.9% vs 10.5% placebo and footnote 1; section 2 rotation and cutaneous amyloidosis; section 6.2.
GLP AI
Editorial
Educational content from the GLP AI team about living on a GLP-1. Clinical review is credited by name on pages a reviewer has checked. Not medical advice.
More GLP-1 side effects
- Nausea & vomitingGLP-1 nausea is the most common side effect: 25–29% on Zepbound and 44% on Wegovy vs 8–16% on placebo. Why it happens, how long it lasts, what helps.
- ConstipationGLP-1 constipation: 11–24% of people on Zepbound or Wegovy in weight-loss trials vs 5–11% on placebo. Fiber and fluid targets, what helps, when to call.
- DiarrheaHow common it is on Zepbound, how long it lasts, what helps and when to call.
- Hair lossGLP-1 hair loss is in the labels: 4–5% on Zepbound and 3% on Wegovy 2.4 mg, vs 1% on placebo. Why it happens, when it regrows, and when to call.
- Fatigue & tirednessDoes GLP-1 make you tired? Fatigue is a labeled side effect: 5–7% on Zepbound, 11% on Wegovy, vs 3–5% on placebo. Causes, what helps, when to call.
- Muscle loss & muscle painGLP-1 muscle loss: about a quarter of the weight lost on tirzepatide in trials was lean mass. How protein and strength training help, and muscle pain.
- HeadacheTirzepatide headache: Zepbound and Mounjaro labels don't list it; Wegovy lists 14% vs 10% on placebo. Common triggers, what helps, when to get help.
- Sulfur burpsSulfur burps on Wegovy, Ozempic, Zepbound or Mounjaro: belching is in every label (up to 7% vs under 1% on placebo). Why, what helps, when to call.
- Insomnia & sleepZepbound insomnia: the label does not list it as a common side effect. What can keep you up on a GLP-1, what helps, and when to call your doctor.
- DizzinessGLP-1 dizziness is a labeled side effect: 8% on Wegovy vs 4% on placebo, 4–5% on Zepbound vs 2%. Common causes to rule out, what helps, when to call.
- Period changesGLP-1 and periods: no label lists cycle changes, but tirzepatide can make the pill less effective. What each label says, and when to call.
- Back painZepbound back pain: no GLP-1 label lists it as a common side effect, but belly pain that spreads to the back is the pancreatitis warning sign.
- Mood, anxiety & depressionCan tirzepatide cause anxiety? Its labels don't list anxiety or depression, and a 2026 FDA review found no added risk. What to know and when to get help.